Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 062844

Expand all

NAFCILLIN SODIUM (NAFCILLIN SODIUM)
EQ 500MG BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: NAFCILLIN SODIUM
Proprietary Name: NAFCILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062844
Product Number: 001
Approval Date: Oct 26, 1988
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NAFCILLIN SODIUM (NAFCILLIN SODIUM)
EQ 1GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: NAFCILLIN SODIUM
Proprietary Name: NAFCILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062844
Product Number: 002
Approval Date: Oct 26, 1988
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NAFCILLIN SODIUM (NAFCILLIN SODIUM)
EQ 1.5GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: NAFCILLIN SODIUM
Proprietary Name: NAFCILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1.5GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062844
Product Number: 003
Approval Date: Oct 26, 1988
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NAFCILLIN SODIUM (NAFCILLIN SODIUM)
EQ 2GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: NAFCILLIN SODIUM
Proprietary Name: NAFCILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062844
Product Number: 004
Approval Date: Oct 26, 1988
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NAFCILLIN SODIUM (NAFCILLIN SODIUM)
EQ 4GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: NAFCILLIN SODIUM
Proprietary Name: NAFCILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 4GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062844
Product Number: 005
Approval Date: Oct 26, 1988
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information